On the basisof clinical,albeit limited, experience,the treatment of obsessional states with intravenous clomipramine holds a great deal of hope. Patients find this method of treatment acceptable. It should be administered on an in-patient basis or in the day hospital and form the focal point of a treatment regimen. Clomipramine infusion appears to be effective in reducing both anxiety and depression and these aspects of its action must be submitted to further study in elucidating its possible attenuating effect on obsessional symptoms. Side-effects, though frequent, are not such that treatment need be abandoned nor are they qualitatively different from those of other tricyclic compounds. Previous papers have suggested the possible value of ...
Obsessive–compulsive disorder is a prevalent and disabling lifespan disorder. Clomipramine and the S...
Clomipramine was seen as a breakthrough for sufferers of obsessive–compulsive disorder (OCD). When i...
Fluvoxamine is the selective serotonin re-uptake inhibitor with the largest database in the treatmen...
Clomipramine has been considered to have specific actions in alleviating chronic depres sion, obsess...
This multicentre double-blind trial in general practice compared the efficacy and tolerability of th...
The aim of this prospectively randomized, double-blind, parallel group, multicentre study was to com...
BACKGROUND. A review of the efficacy of antidepressant drug treatment in patients with obsessive-com...
Twelve subjects with a diagnosis of Obsessive Compulsive Disorder who had not shown response to amit...
intravenous versus continuous oral clomi pramine which had been planned nine months earlier was form...
Panic disorder (PD) is an acute psychobiologic reaction manifested by intense anxiety and panic atta...
Since the discovery that clomipramine was effective in the treatment of obsessive-compulsive disorde...
51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disord...
Eric H Decloedt1, Dan J Stein21Department of Internal Medicine, Division of Clinical Pharmacology, 2...
4BACKGROUND: The objective of this study was to investigate, in a single-blind manner over a period ...
The aim of this study was to explore the possible relationship between plasma clomipramine and its m...
Obsessive–compulsive disorder is a prevalent and disabling lifespan disorder. Clomipramine and the S...
Clomipramine was seen as a breakthrough for sufferers of obsessive–compulsive disorder (OCD). When i...
Fluvoxamine is the selective serotonin re-uptake inhibitor with the largest database in the treatmen...
Clomipramine has been considered to have specific actions in alleviating chronic depres sion, obsess...
This multicentre double-blind trial in general practice compared the efficacy and tolerability of th...
The aim of this prospectively randomized, double-blind, parallel group, multicentre study was to com...
BACKGROUND. A review of the efficacy of antidepressant drug treatment in patients with obsessive-com...
Twelve subjects with a diagnosis of Obsessive Compulsive Disorder who had not shown response to amit...
intravenous versus continuous oral clomi pramine which had been planned nine months earlier was form...
Panic disorder (PD) is an acute psychobiologic reaction manifested by intense anxiety and panic atta...
Since the discovery that clomipramine was effective in the treatment of obsessive-compulsive disorde...
51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disord...
Eric H Decloedt1, Dan J Stein21Department of Internal Medicine, Division of Clinical Pharmacology, 2...
4BACKGROUND: The objective of this study was to investigate, in a single-blind manner over a period ...
The aim of this study was to explore the possible relationship between plasma clomipramine and its m...
Obsessive–compulsive disorder is a prevalent and disabling lifespan disorder. Clomipramine and the S...
Clomipramine was seen as a breakthrough for sufferers of obsessive–compulsive disorder (OCD). When i...
Fluvoxamine is the selective serotonin re-uptake inhibitor with the largest database in the treatmen...